The original rise of Sildenafil presented a considerable opportunity for investors , but its period has ended, creating a challenging landscape. Alternative versions have appeared in the market , eroding sales and putting a strain on profit margins . While major pharmaceutical companies maintain a presence in this field , the potential remains c… Read More